Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses therof
AssigneeMerial Limited
InventorsSusan Mancini Cady, Peter Cheifetz, Izabela Galeska
Life of this patent
Estimating the term…
Abstract
This invention relates to long-acting injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a poloxamer, and a co-solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the long-acting injectable formulations of the invention to the animal in need thereof.
Claims32
A long-acting injectable formulation for the treatment or prevention of parasite infestations or infections in an animal comprising an antiparasitic effective amount of at least one isoxazoline active agent, a poloxamer and, optionally, a co-solvent, wherein no other pharmaceutically acceptable polymers are present.
The long-acting formulation according to any one of paragraphs 1-23, which further comprise an effective amount at least one additional pharmaceutically active agent.
A method for treating or preventing parasites in an animal in need thereof for a period of 3 to 6 months which comprises administering the long acting injectable formulation according to paragraph 1 to said animal.
The use of an isoxazoline in the preparation of a long-acting injectable formulation for the treatment or prevention of a parasite infestation or infection on or in an animal.
Dependencies are inferred from the claim text.